Identification of the novel splicing variants for the hPXR in human livers

被引:52
作者
Fukuen, S
Fukuda, T
Matsuda, H
Sumida, A
Yamamoto, I
Inaba, T
Azuma, J
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[2] Univ Toronto, Fac Med, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
关键词
hPXR; CYP3A4; P-glycoprotein; drug metabolism; splicing variant; alternative splicing; RT-PCR; human liver;
D O I
10.1016/S0006-291X(02)02469-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human pregnane X receptor (hPXR) plays a key role in the regulation of both drug metabolism and efflux by inducing the expression of CYP3A4 and MDR1 gene. Using reverse transcription-polymerase chain reaction (RT-PCR) analysis, we identified seven novel splicing variants of hPXR in tissue from a single human liver. The expression of hPXR-related transcripts in the liver samples of 15 Caucasian individuals was subsequently determined by RT-PCR assays. The pattern of expression levels of these transcripts varied among liver samples. These results suggest that the hPXR is expressed as several different transcripts in liver tissues, apparently due to alternative as well as defective gene splicing. Furthermore, because this study provides the possibility of interindividual differences in hPXR transcript profiles, these alternative splicings for hPXR may largely contribute to the interindividual variability in CYP3A4 and beta-glycoprotein induction. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 23 条
[1]   Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213
[2]   SXR, a novel steroid and xenobiotic-sensing nuclear receptor [J].
Blumberg, B ;
Sabbagh, W ;
Juguilon, H ;
Bolado, J ;
van Meter, CM ;
Ono, ES ;
Evans, RM .
GENES & DEVELOPMENT, 1998, 12 (20) :3195-3205
[3]   UPDATE ON RIFAMPIN DRUG-INTERACTIONS .2. [J].
BORCHERDING, SM ;
BACIEWICZ, AM ;
SELF, TH .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (04) :711-716
[4]  
Dotzlaw H, 1999, CLIN CANCER RES, V5, P2103
[5]   The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin [J].
Greiner, B ;
Eichelbaum, M ;
Fritz, P ;
Kreichgauer, HP ;
Von Richter, O ;
Zundler, J ;
Kroemer, HK .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :147-153
[6]  
Hustert E, 2001, DRUG METAB DISPOS, V29, P1454
[7]   The pregnane x receptor: A promiscuous xenobiotic receptor that has diverged during evolution [J].
Jones, SA ;
Moore, LB ;
Shenk, JL ;
Wisely, GB ;
Hamilton, GA ;
McKee, DD ;
Tomkinson, NCO ;
LeCluyse, EL ;
Lambert, MH ;
Willson, TM ;
Kliewer, SA ;
Moore, JT .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (01) :27-39
[8]   Gene structure prediction and alternative splicing analysis using genomically aligned ESTs [J].
Kan, ZY ;
Rouchka, EC ;
Gish, WR ;
States, DJ .
GENOME RESEARCH, 2001, 11 (05) :889-900
[9]   Steroid receptor isoforms: exception or rule? [J].
Keightley, MC .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 137 (01) :1-5
[10]   IDENTIFICATION OF RIFAMPIN-INDUCIBLE P450IIIA4 (CYP3A4) IN HUMAN SMALL-BOWEL ENTEROCYTES [J].
KOLARS, JC ;
SCHMIEDLINREN, P ;
SCHUETZ, JD ;
FANG, C ;
WATKINS, PB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1871-1878